Investigation Overview
June 12, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Acorda Therapeutics Inc (NASDAQ:ACOR) shares over potential securities laws violations by certain officers and directors at Acorda Therapeutics Inc in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the...
You must register (for free) or login to view the entire investigation.